TETRA BIO-PHARMA WKN: A2ASQ8 ISIN: CA88166Y1007 Kürzel: TBP Forum: Aktien Thema: Hauptdiskussion

Für die Wartezeit ne schöne Zusammenfassung, welche ich selber nur kopiert habe "Here is a summary of points from the AGM -Q4 2010 into Q1 2020 - will be a powerful year for Tetra Bio and Tetra Natural . -Point stressed: the FDA WANTS abuse deterrent technologies in-place to ensure you cannot crush the drug and remove the active moiety to abuse. -No revenue projection given; prefer to surprise instead. -EMA; nothing new to discuss. -Financing; the company acknowledged that shorting may have occurred, however pointed out that financing / stock manipulating unfortunately happens and that if you’re invested long term and believe that the company can bring the pipeline to market then there’s nothing to worry about. -Buyout; not the companies focus. They would “entertain” a suitable offer, however note their priority is executing and getting their drug(s) through trials. -2019/20 major focus: commercialization and securing distribution partners. -Highlight that Tetra spend far less on operational activities than other pharmaceutical companies; skipping drug discovery phase helps here. -Hemorrhoid and cold sore cream targeting 3-400M market in the 🇺🇸. Canadian market is ~10% of this. -They have developed a scanning technique to check for mycotoxins prior to purchase of raw-ingredients. -All partners within the drug supply/development chain but be regulatory complaint. -Market that Tetra are targeting is significantly ($$$) larger than what GW currently targets. Tetra are in good standing to be the first pharmaceutical company to have their cannabinoid drug come to market. Early bird gets the 🐛. -Trump shutting down government last year caused a 3 month delay due to suppliers - Tetra now have a contingency plan in place with additional suppliers to prevent this from occurring again. -Dr Guy Chamberland is a big supporter of getting Tetras name out there through social media and #notacannabiscompany is the hash tag for us all to start using !! -Dr Chamberland will be doing an interview with the European News Agency tomorrow ( link please ? 😇). 👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻"

Link habe ich angefragt. Bisher nur n Screen gesehen

Na dann sag mal an. Link?

Habe deren Auflistung gesehen, wofür das Geld ist... Lohnt sich definitiv 🎉🚀🎉🚀🎉

Nuja. 0.22 is auch ok. Aber hey. Vor einem Monat bei 0.42. mhe. Ja. Aber die Verwässerung ist schon ordentlich

Finde 20% aber dennoch verhältnismäßig viel.

Verwässern um Kohle für ihre Forschung aufzutreiben

Habe ich hier doch gepostet

Ja 20% ist enorm. Frage mich, warum.

Das schon ne Menge

Haben über 20% gestern und heute in Summe eingebüßt.

0.22 oder 0.23 Briefkurs würden mir reichen

Zweifel dran, dass es soweit runter geht ...

Bei 0.20 denk ich nach einzusteigen

😑 reicht langsam..

Nuja. Und die müssen auch noch in die Börse eingearbeitet werden. Darum geht es noch bisl runter! Ähnlich krass hat es sich bei Yield Growth verhalten.